Global and United States Oral Proteins and Peptides Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

Market Analysis and Insights: Global and United States Oral Proteins and Peptides Market

This report focuses on global and United States Oral Proteins and Peptides market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Oral Proteins and Peptides market size is estimated to be worth US$ 2967.6 million in 2022 and is forecast to a readjusted size of US$ 6889.3 million by 2028 with a CAGR of 15.1% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Linaclotide accounting for % of the Oral Proteins and Peptides global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Gastric & Digestive Disorders was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Ironwood & Allergan is one of the most important global  manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

Global Oral Proteins and Peptides Scope and Market Size
Oral Proteins and Peptides market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Oral Proteins and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Oral Proteins and Peptides market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Linaclotide
    Insulin
    Plecanatide
    Cyclosporine
    Octreotide

Segment by Application
    Gastric & Digestive Disorders
    Bone Diseases
    Diabetes
    Hormonal Disorders

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Ironwood & Allergan
    Novo Nordisk
    Synergy Pharmaceuticals （Salix）
    Novartis
    Chiasma (Amryt Pharma)

 1 Study Coverage
    1.1 Oral Proteins and Peptides Product Introduction
    1.2 Global Oral Proteins and Peptides Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Oral Proteins and Peptides Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Oral Proteins and Peptides Sales in Volume for the Year 2017-2028
    1.3 United States Oral Proteins and Peptides Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Oral Proteins and Peptides Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Oral Proteins and Peptides Sales in Volume for the Year 2017-2028
    1.4 Oral Proteins and Peptides Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Oral Proteins and Peptides in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Oral Proteins and Peptides Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Oral Proteins and Peptides Market Dynamics
        1.5.1 Oral Proteins and Peptides Industry Trends
        1.5.2 Oral Proteins and Peptides Market Drivers
        1.5.3 Oral Proteins and Peptides Market Challenges
        1.5.4 Oral Proteins and Peptides Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Oral Proteins and Peptides Market Segment by Type
        2.1.1 Linaclotide
        2.1.2 Insulin
        2.1.3 Plecanatide
        2.1.4 Cyclosporine
        2.1.5 Octreotide
    2.2 Global Oral Proteins and Peptides Market Size by Type
        2.2.1 Global Oral Proteins and Peptides Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Oral Proteins and Peptides Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Oral Proteins and Peptides Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Oral Proteins and Peptides Market Size by Type
        2.3.1 United States Oral Proteins and Peptides Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Oral Proteins and Peptides Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Oral Proteins and Peptides Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Oral Proteins and Peptides Market Segment by Application
        3.1.1 Gastric & Digestive Disorders
        3.1.2 Bone Diseases
        3.1.3 Diabetes
        3.1.4 Hormonal Disorders
    3.2 Global Oral Proteins and Peptides Market Size by Application
        3.2.1 Global Oral Proteins and Peptides Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Oral Proteins and Peptides Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Oral Proteins and Peptides Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Oral Proteins and Peptides Market Size by Application
        3.3.1 United States Oral Proteins and Peptides Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Oral Proteins and Peptides Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Oral Proteins and Peptides Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Oral Proteins and Peptides Competitor Landscape by Company
    4.1 Global Oral Proteins and Peptides Market Size by Company
        4.1.1 Top Global Oral Proteins and Peptides Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Oral Proteins and Peptides Revenue by Manufacturer (2017-2022)
        4.1.3 Global Oral Proteins and Peptides Sales by Manufacturer (2017-2022)
        4.1.4 Global Oral Proteins and Peptides Price by Manufacturer (2017-2022)
    4.2 Global Oral Proteins and Peptides Concentration Ratio (CR)
        4.2.1 Oral Proteins and Peptides Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Proteins and Peptides in 2021
        4.2.3 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Oral Proteins and Peptides Manufacturing Base Distribution, Product Type
        4.3.1 Global Oral Proteins and Peptides Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Oral Proteins and Peptides Product Type
        4.3.3 Date of International Manufacturers Enter into Oral Proteins and Peptides Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Oral Proteins and Peptides Market Size by Company
        4.5.1 Top Oral Proteins and Peptides Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Oral Proteins and Peptides Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Oral Proteins and Peptides Sales by Players (2020, 2021 & 2022)

 5 Global Oral Proteins and Peptides Market Size by Region
    5.1 Global Oral Proteins and Peptides Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Oral Proteins and Peptides Market Size in Volume by Region (2017-2028)
        5.2.1 Global Oral Proteins and Peptides Sales in Volume by Region: 2017-2022
        5.2.2 Global Oral Proteins and Peptides Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Oral Proteins and Peptides Market Size in Value by Region (2017-2028)
        5.3.1 Global Oral Proteins and Peptides Sales in Value by Region: 2017-2022
        5.3.2 Global Oral Proteins and Peptides Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Oral Proteins and Peptides Market Size YoY Growth 2017-2028
        6.1.2 North America Oral Proteins and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Oral Proteins and Peptides Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Oral Proteins and Peptides Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Oral Proteins and Peptides Market Size YoY Growth 2017-2028
        6.3.2 Europe Oral Proteins and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Oral Proteins and Peptides Market Size YoY Growth 2017-2028
        6.4.2 Latin America Oral Proteins and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Oral Proteins and Peptides Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Ironwood & Allergan
        7.1.1 Ironwood & Allergan Corporation Information
        7.1.2 Ironwood & Allergan Description and Business Overview
        7.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Ironwood & Allergan Oral Proteins and Peptides Products Offered
        7.1.5 Ironwood & Allergan Recent Development
    7.2 Novo Nordisk
        7.2.1 Novo Nordisk Corporation Information
        7.2.2 Novo Nordisk Description and Business Overview
        7.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Novo Nordisk Oral Proteins and Peptides Products Offered
        7.2.5 Novo Nordisk Recent Development
    7.3 Synergy Pharmaceuticals （Salix）
        7.3.1 Synergy Pharmaceuticals （Salix） Corporation Information
        7.3.2 Synergy Pharmaceuticals （Salix） Description and Business Overview
        7.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Products Offered
        7.3.5 Synergy Pharmaceuticals （Salix） Recent Development
    7.4 Novartis
        7.4.1 Novartis Corporation Information
        7.4.2 Novartis Description and Business Overview
        7.4.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Novartis Oral Proteins and Peptides Products Offered
        7.4.5 Novartis Recent Development
    7.5 Chiasma (Amryt Pharma)
        7.5.1 Chiasma (Amryt Pharma) Corporation Information
        7.5.2 Chiasma (Amryt Pharma) Description and Business Overview
        7.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Products Offered
        7.5.5 Chiasma (Amryt Pharma) Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Oral Proteins and Peptides Industry Chain Analysis
    8.2 Oral Proteins and Peptides Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Oral Proteins and Peptides Distributors
    8.3 Oral Proteins and Peptides Production Mode & Process
    8.4 Oral Proteins and Peptides Sales and Marketing
        8.4.1 Oral Proteins and Peptides Sales Channels
        8.4.2 Oral Proteins and Peptides Distributors
    8.5 Oral Proteins and Peptides Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Oral Proteins and Peptides CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Oral Proteins and Peptides Market Trends
    Table 3. Oral Proteins and Peptides Market Drivers
    Table 4. Oral Proteins and Peptides Market Challenges
    Table 5. Oral Proteins and Peptides Market Restraints
    Table 6. Global Oral Proteins and Peptides Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Oral Proteins and Peptides Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Oral Proteins and Peptides Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Oral Proteins and Peptides Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Oral Proteins and Peptides Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Oral Proteins and Peptides Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Oral Proteins and Peptides Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Oral Proteins and Peptides Sales by Manufacturer, (Kg), 2017-2022
    Table 14. Global Oral Proteins and Peptides Sales Share by Manufacturer, 2017-2022
    Table 15. Global Oral Proteins and Peptides Price by Manufacturer (2017-2022) & (US$/Mg)
    Table 16. Global Oral Proteins and Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Proteins and Peptides as of 2021)
    Table 18. Top Players of Oral Proteins and Peptides in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Oral Proteins and Peptides Product Type
    Table 20. Date of International Manufacturers Enter into Oral Proteins and Peptides Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Oral Proteins and Peptides Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Oral Proteins and Peptides Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Oral Proteins and Peptides Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Oral Proteins and Peptides Sales by Players, (Kg), 2020, 2021 & 2022
    Table 26. United States Oral Proteins and Peptides Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Oral Proteins and Peptides Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Oral Proteins and Peptides Sales in Volume by Region (2017-2022) & (Kg)
    Table 29. Global Oral Proteins and Peptides Sales in Volume Forecast by Region (2023-2028) & (Kg)
    Table 30. Global Oral Proteins and Peptides Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Oral Proteins and Peptides Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Oral Proteins and Peptides Sales in Volume by Country (2017-2028) & (Kg)
    Table 33. North America Oral Proteins and Peptides Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Oral Proteins and Peptides Sales in Volume by Region (2017-2028) & (Kg)
    Table 35. Asia Pacific Oral Proteins and Peptides Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Oral Proteins and Peptides Sales in Volume by Country (2017-2028) & (Kg)
    Table 37. Europe Oral Proteins and Peptides Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Oral Proteins and Peptides Sales in Volume by Country (2017-2028) & (Kg)
    Table 39. Latin Americaa Oral Proteins and Peptides Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Oral Proteins and Peptides Sales in Volume by Country (2017-2028) & (Kg)
    Table 41. Middle East and Africa Oral Proteins and Peptides Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Ironwood & Allergan Corporation Information
    Table 43. Ironwood & Allergan Description and Business Overview
    Table 44. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
    Table 45. Ironwood & Allergan Oral Proteins and Peptides Product
    Table 46. Ironwood & Allergan Recent Development
    Table 47. Novo Nordisk Corporation Information
    Table 48. Novo Nordisk Description and Business Overview
    Table 49. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
    Table 50. Novo Nordisk Product
    Table 51. Novo Nordisk Recent Development
    Table 52. Synergy Pharmaceuticals （Salix） Corporation Information
    Table 53. Synergy Pharmaceuticals （Salix） Description and Business Overview
    Table 54. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
    Table 55. Synergy Pharmaceuticals （Salix） Product
    Table 56. Synergy Pharmaceuticals （Salix） Recent Development
    Table 57. Novartis Corporation Information
    Table 58. Novartis Description and Business Overview
    Table 59. Novartis Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
    Table 60. Novartis Product
    Table 61. Novartis Recent Development
    Table 62. Chiasma (Amryt Pharma) Corporation Information
    Table 63. Chiasma (Amryt Pharma) Description and Business Overview
    Table 64. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
    Table 65. Chiasma (Amryt Pharma) Product
    Table 66. Chiasma (Amryt Pharma) Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Oral Proteins and Peptides Customers List
    Table 70. Oral Proteins and Peptides Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Proteins and Peptides Product Picture
    Figure 2. Global Oral Proteins and Peptides Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Oral Proteins and Peptides Market Size 2017-2028 (US$ Million)
    Figure 4. Global Oral Proteins and Peptides Sales 2017-2028 (Kg)
    Figure 5. United States Oral Proteins and Peptides Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Oral Proteins and Peptides Market Size 2017-2028 (US$ Million)
    Figure 7. United States Oral Proteins and Peptides Sales 2017-2028 (Kg)
    Figure 8. United States Oral Proteins and Peptides Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Oral Proteins and Peptides Market Share in Global, in Volume (Kg) 2017-2028
    Figure 10. Oral Proteins and Peptides Report Years Considered
    Figure 11. Product Picture of Linaclotide
    Figure 12. Product Picture of Insulin
    Figure 13. Product Picture of Plecanatide
    Figure 14. Product Picture of Cyclosporine
    Figure 15. Product Picture of Octreotide
    Figure 16. Global Oral Proteins and Peptides Market Share by Type in 2022 & 2028
    Figure 17. Global Oral Proteins and Peptides Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Oral Proteins and Peptides Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Oral Proteins and Peptides Sales by Type (2017-2028) & (Kg)
    Figure 20. Global Oral Proteins and Peptides Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Oral Proteins and Peptides Price by Type (2017-2028) & (US$/Mg)
    Figure 22. United States Oral Proteins and Peptides Market Share by Type in 2022 & 2028
    Figure 23. United States Oral Proteins and Peptides Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Oral Proteins and Peptides Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Oral Proteins and Peptides Sales by Type (2017-2028) & (Kg)
    Figure 26. United States Oral Proteins and Peptides Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Oral Proteins and Peptides Price by Type (2017-2028) & (US$/Mg)
    Figure 28. Product Picture of Gastric & Digestive Disorders
    Figure 29. Product Picture of Bone Diseases
    Figure 30. Product Picture of Diabetes
    Figure 31. Product Picture of Hormonal Disorders
    Figure 32. Global Oral Proteins and Peptides Market Share by Application in 2022 & 2028
    Figure 33. Global Oral Proteins and Peptides Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Oral Proteins and Peptides Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Oral Proteins and Peptides Sales by Application (2017-2028) & (Kg)
    Figure 36. Global Oral Proteins and Peptides Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Oral Proteins and Peptides Price by Application (2017-2028) & (US$/Mg)
    Figure 38. United States Oral Proteins and Peptides Market Share by Application in 2022 & 2028
    Figure 39. United States Oral Proteins and Peptides Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Oral Proteins and Peptides Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Oral Proteins and Peptides Sales by Application (2017-2028) & (Kg)
    Figure 42. United States Oral Proteins and Peptides Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Oral Proteins and Peptides Price by Application (2017-2028) & (US$/Mg)
    Figure 44. North America Oral Proteins and Peptides Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 45. North America Oral Proteins and Peptides Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. United States Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe Oral Proteins and Peptides Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 49. Europe Oral Proteins and Peptides Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific Oral Proteins and Peptides Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 56. Asia-Pacific Oral Proteins and Peptides Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Oral Proteins and Peptides Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 67. Latin America Oral Proteins and Peptides Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Oral Proteins and Peptides Sales in Volume Growth Rate 2017-2028 (Kg)
    Figure 72. Middle East & Africa Oral Proteins and Peptides Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Oral Proteins and Peptides Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Oral Proteins and Peptides Value Chain
    Figure 77. Oral Proteins and Peptides Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

Market Analysis and Insights: Global and United States Oral Proteins and Peptides Market

This report focuses on global and United States Oral Proteins and Peptides market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Oral Proteins and Peptides market size is estimated to be worth US$ 2967.6 million in 2022 and is forecast to a readjusted size of US$ 6889.3 million by 2028 with a CAGR of 15.1% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Linaclotide accounting for % of the Oral Proteins and Peptides global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Gastric & Digestive Disorders was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Ironwood & Allergan is one of the most important global  manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

Global Oral Proteins and Peptides Scope and Market Size
Oral Proteins and Peptides market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Oral Proteins and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Oral Proteins and Peptides market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Linaclotide
    Insulin
    Plecanatide
    Cyclosporine
    Octreotide

Segment by Application
    Gastric & Digestive Disorders
    Bone Diseases
    Diabetes
    Hormonal Disorders

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Ironwood & Allergan
    Novo Nordisk
    Synergy Pharmaceuticals （Salix）
    Novartis
    Chiasma (Amryt Pharma)